Stock Analysis

Insider Buying: The Swedencare AB (publ) (STO:SECARE) Chief Executive Officer Just Bought kr162k Worth Of Shares

OM:SECARE
Source: Shutterstock

Even if it's not a huge purchase, we think it was good to see that Hakan Lagerberg, the Chief Executive Officer of Swedencare AB (publ) (STO:SECARE) recently shelled out kr162k to buy stock, at kr80.77 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.

Check out our latest analysis for Swedencare

Advertisement

The Last 12 Months Of Insider Transactions At Swedencare

Notably, that recent purchase by Hakan Lagerberg is the biggest insider purchase of Swedencare shares that we've seen in the last year. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of kr94.92. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
OM:SECARE Insider Trading Volume May 31st 2022

Swedencare is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Swedencare Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. It's great to see that Swedencare insiders own 15% of the company, worth about kr2.2b. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Does This Data Suggest About Swedencare Insiders?

It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. When combined with notable insider ownership, these factors suggest Swedencare insiders are well aligned, and quite possibly think the share price is too low. Nice! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Swedencare. At Simply Wall St, we found 3 warning signs for Swedencare that deserve your attention before buying any shares.

Of course Swedencare may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OM:SECARE

Swedencare

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Solid track record with reasonable growth potential.

Advertisement